ORAL track · Line fact-sheet v0.2

OralBio™ — one oral EV platform, six segment programs

OralBio™ line pack shot

OralBio™ is TONGNIAN's oral EV line: softgels and liquids built on one characterized EV base, scoped for US dietary-supplement and EU novel-food routes first, with China blue-hat as an added market. The EV material is produced on the fully enclosed 0.5–5 L micro-batch line; every batch ships with a COA, and oral formulas carry payload and stability checks on retained samples.

Who this line serves

  • health-monitoring seniors (60–70) — daily softgel programs within routine health management.
  • joint-comfort seniors (65+) — joint-comfort softgel pairings for mobility routines.
  • women on fertility journeys (30–42) — gentle daily-ritual liquids within preconception wellness programs.
  • midlife metabolic programs (45–60) — metabolic-companion softgels alongside diet and exercise routines.
  • menopausal routines (45–55) — stage-specific daily softgels within women's 45+ programs.
  • daily vitality (30–40) — anti-fatigue formats for high-load work seasons.

Line programs

ProgramPopulationDosage formStatus
Daily vital softgel (senior daily formula)Health-monitoring seniorsSoftgel, 60-count (sample)Filing-route design
Joint-comfort softgelSeniors and midlife with joint concernsSoftgel, 60-count (sample)Pilot-ready
Ovarian-stage daily liquidPreconception stageOral liquid, 30-day course (sample)Program design stage
Metabolic-companion softgelMidlife metabolicSoftgel, 60-count (sample)Pilot-ready
Menopause-stage softgelMenopause stageSoftgel, 60-count (sample)Program design stage
Daily vitality liquidHigh-load professionalsOral liquid / drops (sample)Pilot-ready

Why brands build on OralBio™

  • One platform, many segments — the same characterized EV base re-expressed per population, so brands launch a family rather than isolated SKUs.
  • Filing-route clarity — each program is scoped against its destination-market route before art development begins.
  • Course-sized retail — 60-count softgel jars and 30-day liquid courses match the once-daily label and the refill cycle.
  • Documented batches — batch COA with every shipment; payload and stability on retained samples.

Specs & characterization

ItemValue
EV systemCharacterized EV base (marine-fermented and plant fractions per program)
Vesicle size (NTA)80–200 nm range by program (sample)
FormatsSoftgels, oral liquids, drops (sample configurations)
QC panelPayload & stability, microbial limits, NTA, TEM, endotoxin (LAL); batch COA
StorageCool, dry, light-protected (sample); material line: −20 °C 60 days / −80 °C 360 days
Compliance statusEV material line: FDA DMF Type II 044197 · INCI 41316; finished goods per destination-market filing route
Typical programPilot from 500 units · production from 2,000 units · standard lead 15 workdays

Quality & compliance

  • US supplement disclaimer — "These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease."
  • Filing-first — the finished good files per destination market (US dietary supplement, EU novel food); OralBio supplies the EV material documentation chain behind it.
  • Material chain — DMF Type II 044197 and INCI 41316 on the EV material line; batch COAs with every shipment.
  • Closed line — EV base produced on the fully enclosed micro-batch platform.
  • Claim discipline — routine-companion positioning; efficacy references stay in internal observational files with journal citations.

Material background: milk-derived exosome carriers improved oral bioavailability in human intervention studies (Molecular Nutrition & Food Research, 2026). Cited as material-science background — not a product claim.

Work with this line: pick your segment program via Request a quote, or review the OBM program for a full family launch.

Request a quote

Customize OralBio™ dosage forms and skin feel for your brand.

Share your brand stage and target category, and we’ll return sample specs, an MOQ framework, and characterization samples (typical: sample kits in 3–5 days); to review the full-line design first, head to Knowledge · Solutions.

Request a quote